Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2009
Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitisJianfeng Wang, Zi-Hua Lu, Hans-Joachim Gabius, et al.Experimental Neurology|March 14, 2020
Mice deficient in GM1 manifest both motor and non-motor symptoms of Parkinson's disease; successful treatment with synthetic GM1 gangliosideGusheng Wu, Zi-Hua Lu, Joon Ho Seo, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 25, 2005
Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1Gusheng Wu, Zi-Hua Lu, Jianfeng Wang, et al.Annals of the New York Academy of Sciences|April 25, 2012
Beyond glycoproteins as galectin counterreceptors: tumor-effector T cell growth control via ganglioside GM1 [corrected]Robert W Ledeen, Gusheng Wu, Sabine André, et al.Journal of Neurochemistry|January 27, 2007
Bimodal occurrence of aspartoacylase in myelin and cytosol of brainJianfeng Wang, Reuben Matalon, Gita Bhatia, et al.Neurochemical Research|May 15, 2008
Myelin lipid abnormalities in the aspartoacylase-deficient tremor ratJianfeng Wang, Paola Leone, Gusheng Wu, et al.Experimental Neurology|December 3, 2014
GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine modelPiotr Hadaczek, Gusheng Wu, Nitasha Sharma, et al.Scientific Reports|December 20, 2019
Parkinson's disease recovery by GM1 oligosaccharide treatment in the B4galnt1<sup>+/-</sup> mouse modelElena Chiricozzi, Laura Mauri, Giulia Lunghi, et al.Pageof 4